Management of Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) in Pregnancy

Multiple acyl-CoA dehydrogenase deficiency (MADD), also known as glutaric acidemia/glutaric aciduria type II (GA II), is an inborn error of fatty acid, amino acid, and choline metabolism. The chronic management of MADD involves both dietary fat and protein restriction to reduce the substrates of the dehydrogenases affected, the avoidance of prolonged fasting as in any fat metabolism disorder, and monitoring for potential complications. Due to its rarity, there is little published experience on the management of MADD in pregnancy. Herein, we report the successful management of a pregnancy in a patient with late-onset or type III MADD, with considerations for preconception, antepartum, intrapartum, and postpartum care.

Authors

Institutions

Publication Details

Journal
Metabolites
Published
2025-06-24
DOI
https://doi.org/10.3390/metabo15070432
Citations
1
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
1.32
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management of Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) in Pregnancy

Matthew A. Shear, Annalisa Post, Renata C. Gallagher, Irene J. Chang et al.
1 citations
Metabolites
Metabolism and Genetic Disorders
1.32
article

Management of Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) in Pregnancy

Matthew A. Shear, Annalisa Post, Renata C. Gallagher, Irene J. Chang, Allie LaTray
article en
1 citations

Abstract

Multiple acyl-CoA dehydrogenase deficiency (MADD), also known as glutaric acidemia/glutaric aciduria type II (GA II), is an inborn error of fatty acid, amino acid, and choline metabolism. The chronic management of MADD involves both dietary fat and protein restriction to reduce the substrates of the dehydrogenases affected, the avoidance of prolonged fasting as in any fat metabolism disorder, and monitoring for potential complications. Due to its rarity, there is little published experience on the management of MADD in pregnancy. Herein, we report the successful management of a pregnancy in a patient with late-onset or type III MADD, with considerations for preconception, antepartum, intrapartum, and postpartum care.

MetabolitesVol. 15(7)
University of California, San Francisco (US)
Good health and well-being
Openalex Percentile: Top 18%
Metabolism and Genetic Disorders
1.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Management of Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) in Pregnancy — Matthew A. Shear, Annalisa Post, et al. · Metabolites (2025) | TGRS Research Map | TGRS